tenk.fyi

Larimar Therapeutics, Inc.

LRMRNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$165.7M

105.5% YoY

EPS

-

Cash

$85.4M

157.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro